Freestone Grove Partners’s Tenet Healthcare THC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$19.7M Buy
+104,187
New +$22M 0.14% 211
2025
Q4
Sell
-134,197
Closed -$27.2M 941
2025
Q3
$27.2M Sell
134,197
-93,833
-41% -$16.6M 0.2% 168
2025
Q2
$40.1M Sell
228,030
-49,468
-18% -$7.45M 0.3% 125
2025
Q1
$37.3M Buy
+277,498
New +$36.5M 0.38% 86

Other funds holding THC

Freestone Grove Partners's THC Position: Q1 2026 in Review

Freestone Grove Partners opened a new position in Tenet Healthcare (THC) in Q1 2026: 104,187 shares worth $19.7M. The stake represents 0.14% of the portfolio and ranks #211 among its holdings. This is a return to the name: Freestone Grove Partners previously reported a position in THC as recently as Q3 2025.

Freestone Grove Partners first reported a position in THC in Q1 2025 and has held it in 4 quarters since. The position peaked at $40.1M in Q2 2025. 690 funds tracked by Wall St. Rank hold THC as of Q1 2026.

  • Freestone Grove Partners held 104,187 shares of Tenet Healthcare worth $19.7M as of Q1 2026.
  • Tenet Healthcare was a new Freestone Grove Partners position in Q1 2026.
  • Tenet Healthcare made up 0.14% of Freestone Grove Partners's portfolio in Q1 2026, its #211 holding.
  • Freestone Grove Partners first reported a position in Tenet Healthcare in Q1 2025 and has held it in 4 quarters since.
  • Freestone Grove Partners's Tenet Healthcare position peaked at $40.1M in Q2 2025.
  • 690 funds tracked by Wall St. Rank held Tenet Healthcare as of Q1 2026.

Based on Freestone Grove Partners's 13F filing for Q1 2026, filed 15 May 2026.